XRCC4 and endometrial cancer: According to the analysis result, the highest frequency of XRCC4 alteration appeared for pan-cancer patients with adrenocortical carcinoma (ACC), endometrial cancer, ovarian and melanoma (> 2%) using the cBioPortal database.